Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Induced pluripotent stem cells: a tool for modeling Parkinson’s disease
Anindita Bose, Gregory A. Petsko, Lorenz Studer
Trends in Neurosciences (2022) Vol. 45, Iss. 8, pp. 608-620
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Advances in understanding the function of alpha-synuclein: implications for Parkinson’s disease
Paolo Calabresi, Giulia Di Lazzaro, Gioia Marino, et al.
Brain (2023) Vol. 146, Iss. 9, pp. 3587-3597
Open Access | Times Cited: 60
Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
Jessica R. Cohen, Annette Mathew, Kirk D. Dourvetakis, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 511-511
Open Access | Times Cited: 29
Brain organoid protocols and limitations
Helen Zhao, Gabriel G. Haddad
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 15
Therapeutic Reprogramming toward Regenerative Medicine
Sheng Ding
Chemical Reviews (2025)
Closed Access | Times Cited: 1
Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies
Douglas Bottega Pazzin, Thales Thor Ramos Previato, João Ismael Budelon Gonçalves, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 745-745
Open Access | Times Cited: 6
Evidence for Oxidative Pathways in the Pathogenesis of PD: Are Antioxidants Candidate Drugs to Ameliorate Disease Progression?
Alexander Leathem, Tamara Ortíz, Joanne M. Dennis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6923-6923
Open Access | Times Cited: 26
Genetic Evidence for Endolysosomal Dysfunction in Parkinson’s Disease: A Critical Overview
Vidal Yahya, Alessio Di Fonzo, Edoardo Monfrini
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6338-6338
Open Access | Times Cited: 12
An engineered Sox17 induces somatic to neural stem cell fate transitions independently from pluripotency reprogramming
Mingxi Weng, Haoqing Hu, Matthew S. Graus, et al.
Science Advances (2023) Vol. 9, Iss. 34
Open Access | Times Cited: 11
Chronic and acute exposure to rotenone reveals distinct Parkinson's disease-related phenotypes in human iPSC-derived peripheral neurons
Mahmood Ali Saleh, Fatima Amer‐Sarsour, Asaf Berant, et al.
Free Radical Biology and Medicine (2024) Vol. 213, pp. 164-173
Open Access | Times Cited: 4
Novel Poly-Arginine Peptide R18D Reduces α-Synuclein Aggregation and Uptake of α-Synuclein Seeds in Cortical Neurons
Emma C. Robinson, Anastazja M. Gorecki, Sabino Pesce, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 122-122
Open Access
Regenerating Locus Coeruleus‐Norepinephrine (LC‐NE) Function: A Novel Approach for Neurodegenerative Diseases
Ya-Na Yang, Yunlong Tao
Cell Proliferation (2025)
Open Access
iPSC models of mitochondrial diseases
Sonja Heiduschka, Alessandro Prigione
Neurobiology of Disease (2025), pp. 106822-106822
Open Access
Cell reprogramming: methods, mechanisms and applications
Fei Zhu, Guangjun Nie
Cell Regeneration (2025) Vol. 14, Iss. 1
Open Access
On the implementation of single-cell omics and CRISPR screens for iPSC-models of Parkinson’s disease
Victoria Lievens, Hugo J. R. Fernandes
Brain Organoid and Systems Neuroscience Journal (2025)
Open Access
Current Development of iPSC-Based Modeling in Neurodegenerative Diseases
Xiangge Guo, Xumeng Wang, Jiaxuan Wang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3774-3774
Open Access
Chemical-based epigenetic reprogramming to advance pluripotency and totipotency
Shanshan Wen, Ran Zheng, Cheguo Cai, et al.
Nature Chemical Biology (2025)
Closed Access
Mendelian Randomization Study Using Dopaminergic Neuron‐Specific eQTL Nominates Potential Causal Genes for Parkinson's Disease
Xinglun Dang, Zhijun Zhang, Xiong‐Jian Luo
Movement Disorders (2022) Vol. 37, Iss. 12, pp. 2451-2456
Closed Access | Times Cited: 18
Advances in Human Cellular Mechanistic Understanding and Drug Discovery of Brain Organoids for Neurodegenerative Diseases
Lei Tong, Xiaoshuang Zhang, Gaoshuang Fu, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102517-102517
Closed Access | Times Cited: 3
The multifaceted role of LRRK2 in Parkinson's disease: From human iPSC to organoids
Asmaa Oun, Angélica María Sabogal-Guáqueta, Sekar Galuh, et al.
Neurobiology of Disease (2022) Vol. 173, pp. 105837-105837
Open Access | Times Cited: 11
Organ-Chips Enhance the Maturation of Human iPSC-Derived Dopamine Neurons
María Gabriela Otero, Shaughn Bell, Alex Laperle, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14227-14227
Open Access | Times Cited: 4
Identification of the bacterial metabolite aerugine as potential trigger of human dopaminergic neurodegeneration
Anna‐Katharina Ückert, Sina Rütschlin, Simon Gutbier, et al.
Environment International (2023) Vol. 180, pp. 108229-108229
Open Access | Times Cited: 4
iSCORE-PD: an isogenic stem cell collection to research Parkinson’s Disease
Oriol Busquets, Hanqin Li, Khaja Syed, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice
Tiago F. Outeiro, Lorraine V. Kalia, Erwan Bézard, et al.
Movement Disorders (2024) Vol. 39, Iss. 6, pp. 929-933
Open Access | Times Cited: 1
Single-cell transcriptomic changes in oligodendrocytes and precursors derived from Parkinson's disease patient-iPSCs with LRRK2-G2019S mutation
Mohammad Dehestani, Wiebke Kessler, Nasser Karmali, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease
Jeffrey Kim, Etienne W. Daadi, Thomas Oh, et al.
Genes (2022) Vol. 13, Iss. 11, pp. 1937-1937
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top